Structural comparison of two anti-CD20 monoclonal antibody drug products using middle-down mass spectrometry.
about
Pepsin-Containing Membranes for Controlled Monoclonal Antibody Digestion Prior to Mass Spectrometry Analysis.A new tool for monoclonal antibody analysis: application of IdeS proteolysis in IgG domain-specific characterization.Rapid Fc glycosylation analysis of Fc fusions with IdeS and liquid chromatography mass spectrometryComparison of methods for the analysis of therapeutic immunoglobulin G Fc-glycosylation profiles-Part 2: Mass spectrometric methods.Characterization of Pharmaceutical IgG and Biosimilars Using Miniaturized Platforms and LC-MS/MS.Comparison of methods for the analysis of therapeutic immunoglobulin G Fc-glycosylation profiles--part 1: separation-based methodsPerformance metrics for evaluating system suitability in liquid chromatography--Mass spectrometry peptide mass mapping of protein therapeutics and monoclonal antibodies.The use of lectin microarray for assessing glycosylation of therapeutic proteins.Post-translational structural modifications of immunoglobulin G and their effect on biological activity.Rapid and improved characterization of therapeutic antibodies and antibody related products using IdeS digestion and subunit analysis.Top-down analysis of immunoglobulin G isotypes 1 and 2 with electron transfer dissociation on a high-field Orbitrap mass spectrometer.Subunit mass analysis for monitoring antibody oxidation.An integrated top-down and bottom-up proteomic approach to characterize the antigen-binding fragment of antibodies.A whole-molecule immunocapture LC-MS approach for the in vivo quantitation of biotherapeutics.
P2860
Q30278544-B72F9200-6241-4487-AF47-CE9E6105084DQ34223967-E408C14D-0324-4027-A01E-022B1A248095Q34803946-AB0B48A5-C988-46E3-9E2D-C83ACF31EB20Q35637901-4A0261FD-627D-4A15-9313-56108796AA47Q35975965-DC1A5DC1-5ABA-4732-ABC6-CE4C2D6E5F5BQ36216323-E26092AF-E733-4F1B-A16E-6F90E9E4E3ACQ37138041-69C75ED6-34FB-42B1-875E-BCE5C5560075Q37138938-13DB1211-F351-4A69-9D55-1E2F520F3941Q38246996-CB34DEF8-CC0C-4742-996E-7AB9BDFE0876Q38828582-7D76E925-94AF-4743-ABC1-926284923948Q38938858-61174297-AE01-4C8E-B867-4CDC2C159C86Q39010405-A1A5D90A-B9A5-423E-9B3C-559B300CCC01Q46888453-F340DBAB-2F1C-409B-95A3-D8AA90A0C7D1Q51525919-9C542996-9EB4-444F-8C3B-528055CC261D
P2860
Structural comparison of two anti-CD20 monoclonal antibody drug products using middle-down mass spectrometry.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Structural comparison of two a ...... middle-down mass spectrometry.
@en
Structural comparison of two a ...... middle-down mass spectrometry.
@nl
type
label
Structural comparison of two a ...... middle-down mass spectrometry.
@en
Structural comparison of two a ...... middle-down mass spectrometry.
@nl
prefLabel
Structural comparison of two a ...... middle-down mass spectrometry.
@en
Structural comparison of two a ...... middle-down mass spectrometry.
@nl
P2093
P2860
P356
P1433
P1476
Structural comparison of two a ...... middle-down mass spectrometry
@en
P2093
Ashley C Gucinski
Lucinda F Buhse
Michael T Boyne
P2860
P304
P356
10.1039/C3AN36524G
P577
2013-05-01T00:00:00Z